Skip to main content
1100 Industrial Road, Suite 1, San Carlos, CA. 94070

Now, we are currently enrolling patients in our INHERIT trial. Learn more.

Past Studies

EGFR INHERIT Study

EGFR INHERIT Study


EGFR INHERIT Study


Lung cancer in never-smokers is the 7th most common malignancy worldwide. Environmental and inherited causes in never-smokers remain uncertain, as well as in other populations without an identifiable risk factor. 

Lung cancer in never-smokers has recently been found identifiable in family members carrying inherited EGFR gene mutations, called T790M. Understanding underlying biology in high-risk families will provide insight into why lung cancer occurs in never-smokers and others; however, such families have been too rare to study systematically. 

INHERIT launched in early December 2012. ALCMI is coordinating tissue collection/analysis and CT-scan banking. Patients with T790M mutation tumors are being tested for underlying inherited T790M mutations and family members are also being recruited. Creating a registry of high-risk families is laying the groundwork for subsequent lung cancer screening and prevention research, irrespective of smoking history.

THIS STUDY IS NOW CLOSED TO ENROLLMENT. 

The second iteration of this trial is currently underway.


Contact Form


Thank you for your interest. This study is now closed to enrollment.

We're currently enrolling patients for the newest INHERIT Trial. Learn more.

Our Impact

  • Total Clinical Trials
    Total Clinical Trials

    23

  • Trial Participants
    Trial Participants

    1,754

  • Publication Citations and Downloads
    Publication Citations and Downloads

    13,659

  • Partners and Sponsors
    Partners and Sponsors

    56

Addario Lung Cancer Medical Institute (ALCMI)
1100 Industrial Road, Suite 1, San Carlos, CA. 94070
MENU CLOSE